BRISTOL-MYERS SQUIBB COMPANY Form SC 13D: Beneficial ownership report (active)
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-04-05: Form SC 13D/A; Description SCHEDULE 13D/A; Document brhc10022784_sc13da.htm.
- 2020-07-16: Form SC 13D/A; Description SCHEDULE 13D/A; Document brhc10013467_sc13da.htm.
- 2019-02-27: Form SC 13D; Description BRISTOL-MYERS SQUIBB COMPANY; Document p19-0752sc13d.htm.
- 2012-01-13: Form SC 13D; Description SCHEDULE 13D; Document d283109dsc13d.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-04-05 | SC 13D/A | SCHEDULE 13D/A | brhc10022784_sc13da.htm | |
| 2020-07-16 | SC 13D/A | SCHEDULE 13D/A | brhc10013467_sc13da.htm | |
| 2019-02-27 | SC 13D | BRISTOL-MYERS SQUIBB COMPANY | p19-0752sc13d.htm | |
| 2012-01-13 | SC 13D | SCHEDULE 13D | d283109dsc13d.htm | |
| 2010-09-15 | SC 13D | SCHEDULE 13D | dsc13d.htm | |
| 2009-12-23 | SC 13D/A | SCHEDULE 13D/A AMENDMENT NO. 6 | dsc13da.htm | |
| 2009-12-15 | SC 13D/A | SCHEDULE 13D AMENDMENT NO. 5 | dsc13da.htm | |
| 2009-12-09 | SC 13D/A | SCHEDULE 13D AMENDMENT NO. 4 | dsc13da.htm | |
| 2009-11-25 | SC 13D/A | SCHEDULE 13D AMENDMENT NO. 3 | dsc13da.htm | |
| 2009-02-27 | SC 13D | SCHEDULE 13D | dsc13d.htm | |
| 2008-10-08 | SC 13D/A | AMENDMENT NO. 6 | sc13da.htm | |
| 2008-09-23 | SC 13D/A | AMENDMENT NO. 5 | sc13da.htm | |
| 2008-07-31 | SC 13D/A | AMENDMENT NO. 4 | sc13da.htm | |
| 2006-02-01 | SC 13D/A | AMENDMENT NO. 3 TO SCHEDULE 13D | dsc13da.htm | |
| 2003-06-06 | SC 13D/A | AMENDMENT NO. 8 FORM 13D/A | dsc13da.htm | |
| 2003-04-16 | SC 13D/A | SCHEDULE 13D | a2108677zsc13da.txt | |
| 2003-02-14 | SC 13D/A | SC 13D/A | a2103656zsc13da.txt | |
| 2003-02-03 | SC 13D/A | SC 13D/A | a2102344zsc13da.txt | |
| 2002-05-15 | SC 13D/A | AMENDMENT NO. 5 TO SC 13D | dsc13da.htm | |
| 2002-03-06 | SC 13D/A | AMENDMENT NO. 2 | sch13d_a.txt | |
| 2002-02-06 | SC 13D/A | SCHEDULE 13D (AMENDMENT NO. 1) | sch13d_a.txt | |
| 2000-11-15 | SC 13D/A | BRISTOL-MYERS SQUIBB COMPANY SC13D AM #4 | 0001.txt | |
| 2000-11-14 | SC 13D/A | BRISTOL-MYERS SQUIBB COMPANY SC13D AM #3 | 0001.txt | |
| 2000-03-10 | SC 13D/A | BRISTOL-MYERS SQUIBB COMPANY SC13D AM #2 | ||
| 1999-02-12 | SC 13D/A | BRISTOL-MYERS SC 13D AM#1 | ||
| 1998-01-09 | SC 13D | SCHEDULE 13D | ||
| 1996-08-07 | SC 13D | CADUS 13D SCHEDULE | ||
| 1996-06-27 | SC 13D | SCHEDULE 13D | ||
| 1996-05-23 | SC 13D | BRISTOL-MYERS SQUIBB 13D | ||
| 1996-04-05 | SC 13D/A | SC 13D AMEND. NO. 1 FOR BRISTOL-MYERS (RE: CONMED) | ||
| 1996-02-06 | SC 13D | 13D FOR CONMED/B-MS | ||
| 1995-10-11 | SC 13D | 13D FOR B-M/ROCHESTER MEDICAL |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |